Showing results (31-40 of 518) with videos related to
Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2023
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?Dipesh Uprety, Jordi Remon, Solange PetersMediastinum (Hong Kong, China)|February 4, 2022
Targeted therapies for unresectable stage III non-small cell lung cancerJordi Remon, Lizza E L HendriksTranslational Lung Cancer Research|July 23, 2021
Immunotherapy in malignant pleural mesothelioma: a review of literature dataJessica Menis, Giulia Pasello, Jordi RemonClinical Lung Cancer|August 16, 2021
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma PatientsJordi Remon, Nicolas Girard, Silvia Novello, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2023
Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural MesotheliomaMarco Tagliamento, Massimo Di Maio, Jordi Remon, et al.Cancers|December 8, 2020
Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung CancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.JTO Clinical and Research Reports|January 8, 2026
Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief ReportAdele Bonato, Claudia Parisi, Priscilla Cascetta, et al.European Journal of Cancer (Oxford, England : 1990)|June 15, 2026
Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancerDanny Lavigne, Cecile Le Péchoux, Angela Botticella, et al.Cancer Treatment Reviews|September 10, 2023
Local control strategies for management of NSCLC with oligoprogressive diseaseAntoine Mavrikios, Jordi Remon, Clément Quevrin, et al.Future Oncology (London, England)|May 16, 2020
Combination treatments with immunotherapy in brain metastases patientsClemence Henon, Jordi Remon, Lizza El HendriksPageof 52